Natixis’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
Natixis's HALO Position: Q1 2026 in Review
Natixis reduced its Halozyme (HALO) stake by 100% in Q1 2026, selling an estimated $32.9M and leaving 1,216 shares worth $78.6K. The position accounts for ﹤0.01% of the portfolio, ranked #956.
Natixis first reported a position in HALO in Q4 2020 and has held it in 16 quarters since. The position peaked at $31.5M in Q4 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Natixis held 1,216 shares of Halozyme worth $78.6K as of Q1 2026.
- Natixis sold 466,292 Halozyme shares in Q1 2026, an estimated $32.9M.
- Halozyme made up ﹤0.01% of Natixis's portfolio in Q1 2026, its #956 holding.
- Natixis first reported a position in Halozyme in Q4 2020 and has held it in 16 quarters since.
- Natixis's Halozyme position peaked at $31.5M in Q4 2025.
- 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.